BioXcel Therapeutics, Inc. logo

BioXcel Therapeutics, Inc.

NASDAQ:BTAI

Overview | Financials
Company Name BioXcel Therapeutics, Inc.
Symbol BTAI
Currency USD
Price 0.351
Market Cap 17,424,742
Dividend Yield 0%
52-week-range 0.3 - 4.17
Industry Biotechnology
Sector Healthcare
CEO Dr. Vimal D. Mehta Ph.D.
Website https://www.bioxceltherapeutics.com

An error occurred while fetching data.

About BioXcel Therapeutics, Inc.

BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. Its commercial

Related Stocks

Fulcrum Therapeutics, Inc. logo

Fulcrum Therapeutics, Inc.

FULC

4.55 USD

Heron Therapeutics, Inc. logo

Heron Therapeutics, Inc.

HRTX

1.58 USD

HilleVax, Inc. logo

HilleVax, Inc.

HLVX

1.87 USD

Absci Corporation logo

Absci Corporation

ABSI

3.01 USD

ALX Oncology Holdings Inc. logo

ALX Oncology Holdings Inc.

ALXO

1.83 USD

Athira Pharma, Inc. logo

Athira Pharma, Inc.

ATHA

0.542 USD

C4 Therapeutics, Inc. logo

C4 Therapeutics, Inc.

CCCC

3.87 USD

OraSure Technologies, Inc. logo

OraSure Technologies, Inc.

OSUR

3.69 USD

EyePoint Pharmaceuticals, Inc. logo

EyePoint Pharmaceuticals, Inc.

EYPT

7.33 USD

Financials

Numbers are in millions USD

Numbers are in millions USD